Rena McKinnon

494 total citations
9 papers, 316 citations indexed

About

Rena McKinnon is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Rena McKinnon has authored 9 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Rena McKinnon's work include PARP inhibition in cancer therapy (2 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Autophagy in Disease and Therapy (1 paper). Rena McKinnon is often cited by papers focused on PARP inhibition in cancer therapy (2 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Autophagy in Disease and Therapy (1 paper). Rena McKinnon collaborates with scholars based in United States, Germany and Australia. Rena McKinnon's co-authors include Jennifer Garrus, Bárbara Müller, Scott G. Morham, Kirsten M. Stray, Hans‐Georg Kräusslich, Wesley I. Sundquist, Tracey C. Fleischer, Kirill Ostanin, J. Jay Boniface and Ryan T. Terry-Lorenzo and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Rena McKinnon

9 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rena McKinnon United States 8 173 94 51 44 37 9 316
Erik C Hansen United States 8 213 1.2× 28 0.3× 88 1.7× 49 1.1× 61 1.6× 11 351
Jordan L. Scott United States 10 274 1.6× 115 1.2× 12 0.2× 87 2.0× 39 1.1× 17 479
Cindy L. Wolfe United States 13 497 2.9× 40 0.4× 34 0.7× 90 2.0× 42 1.1× 18 654
Ian Carter-O’Connell United States 10 274 1.6× 47 0.5× 9 0.2× 27 0.6× 110 3.0× 11 524
M.D. Rackham United Kingdom 7 320 1.8× 43 0.5× 13 0.3× 112 2.5× 22 0.6× 7 517
Déborah Harrus France 11 184 1.1× 44 0.5× 14 0.3× 45 1.0× 41 1.1× 14 297
Zongxing Qiu China 8 133 0.8× 16 0.2× 61 1.2× 164 3.7× 25 0.7× 9 313
M. E. Marongiu Italy 13 156 0.9× 18 0.2× 95 1.9× 70 1.6× 14 0.4× 36 453
Nara Margolin United States 6 241 1.4× 26 0.3× 110 2.2× 41 0.9× 39 1.1× 9 378
Chetan Chintha India 10 200 1.2× 96 1.0× 4 0.1× 65 1.5× 22 0.6× 16 396

Countries citing papers authored by Rena McKinnon

Since Specialization
Citations

This map shows the geographic impact of Rena McKinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rena McKinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rena McKinnon more than expected).

Fields of papers citing papers by Rena McKinnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rena McKinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rena McKinnon. The network helps show where Rena McKinnon may publish in the future.

Co-authorship network of co-authors of Rena McKinnon

This figure shows the co-authorship network connecting the top 25 collaborators of Rena McKinnon. A scholar is included among the top collaborators of Rena McKinnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rena McKinnon. Rena McKinnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Weinstock, Matthew T., Michael T. Jacobsen, Nicolas Szabo‐Fresnais, et al.. (2014). Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets. Protein Science. 24(4). 446–463. 22 indexed citations
2.
Kumar, Dhiraj, Christophe Hoarau, Matthew G. Bursavich, et al.. (2012). Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(13). 4377–4385. 26 indexed citations
3.
Kim, Seho, Ashok C. Bajji, Rajendra Tangallapally, et al.. (2012). Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor. Journal of Medicinal Chemistry. 55(17). 7480–7501. 36 indexed citations
4.
Fleischer, Tracey C., Jeffrey S. Flick, Ryan T. Terry-Lorenzo, et al.. (2010). Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound. Chemistry & Biology. 17(6). 659–664. 44 indexed citations
5.
Lockman, Jeffrey W., Kirill Ostanin, Jeremy Green, et al.. (2010). Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as Potent Inhibitors of Nicotinamide Phosphoribosyltransferase (Nampt). Journal of Medicinal Chemistry. 53(24). 8734–8746. 20 indexed citations
6.
Fleischer, Tracey C., Vijay Baichwal, Chad Bradford, et al.. (2010). Abstract LB-288: MPI-0486348: A novel inhibitor of nicotinamide phosphoribosyltransferase (Nampt) induces tumor regression in a preclinical model. Cancer Research. 70(8_Supplement). LB–288. 2 indexed citations
7.
Garrus, Jennifer, Vijay Baichwal, Michael A. Saunders, et al.. (2008). Triterpene based compounds with potent anti-maturation activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 18(24). 6377–6380. 18 indexed citations
8.
Garrus, Jennifer, Bárbara Müller, Kirsten M. Stray, et al.. (2004). The Human Endosomal Sorting Complex Required for Transport (ESCRT-I) and Its Role in HIV-1 Budding. Journal of Biological Chemistry. 279(34). 36059–36071. 130 indexed citations
9.
McKinnon, Rena, Paul Desmond, Peijing An, et al.. (1987). Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics. Journal of Pharmacy and Pharmacology. 39(7). 522–525. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik C Hansen Breakdown of academic impact, for papers by Jordan L. Scott Breakdown of academic impact, for papers by Cindy L. Wolfe Breakdown of academic impact, for papers by Ian Carter-O’Connell Breakdown of academic impact, for papers by M.D. Rackham Breakdown of academic impact, for papers by Déborah Harrus Breakdown of academic impact, for papers by Zongxing Qiu Breakdown of academic impact, for papers by M. E. Marongiu Breakdown of academic impact, for papers by Nara Margolin Breakdown of academic impact, for papers by Chetan Chintha
Rankless by CCL
2026